• 论坛首页
  • 我的丁香客
  • 找人
    查找好友
  • 更多
    丁香园
    丁香通
    丁香人才
    丁香会议
    丁香搜索
    丁香医生
    丁香无线
    丁香导航
    丁当铺
    文献求助
    医药数据库
    丁香诊所
    来问医生
登录 注册

科技动态

关注今日:2 | 主题:423203
论坛首页  >  医药生命科学动态跟踪   >  生命科学
  • 发帖
    每发1个新帖
    可以获得0.5个丁当奖励
  • 回帖

分享到:

  • 微信

    微信扫一扫

  • 微博
  • 丁香客
  • 复制网址

【bio-news】【science】RIPS,ips领域的创新?关注一下好了

  • 只看楼主
  • 页码直达:
  • 直达末页
楼主 inflyings
inflyings
铁杆站友

  • 11
    积分
  • 4
    得票
  • 144
    丁当
  • 1楼
这个帖子发布于10年零99天前,其中的信息可能已发生改变或有所发展。
Cellular Reprogramming: New Technique RiPS Open Stem Cell Field
Gretchen Vogel

While stem cell scientists in the United States are grappling with continued uncertainty about the future of federal funding for work with embryonic cells (see p. 163), the field got a bit of good news last week: a paper describing a new method for prompting mature cells to take on a different fate. The technique is cleaner, safer, faster, and more efficient than recently developed methods for reprogramming adult cells, promising to give researchers a powerful new tool for making and using stem cells. It "will have a huge impact in the near term," says Justin Ichida, who studies reprogramming at the Harvard Stem Cell Institute and was not involved in the study.

Cleaner, safer, faster. A new technique using synthetic RNA can reprogram adult cells so they are genetically identical to the source cell.

Four years ago, scientists took a major step toward overcoming the biggest ethical hurdle in stem cell research. Instead of using cells derived from embryos, researchers found a way to make adult cells behave as though they were embryonic. Simply inserting extra copies of four genes into these cells gave the cells the ability to develop into almost any cell type in the body. Known as induced pluripotent stem (iPS) cells, these cells are a potential boon for studying and ultimately treating a variety of diseases, and many labs immediately added the technique to their repertoire. Scientists have also used the trick to turn one mature cell type directly into another (skipping the embryonic stage) by inserting key genes for the desired cell type.

But the technique, called cellular reprogramming, has some drawbacks. The reprogrammed cells retain copies of the inserted genes, which makes them prone to forming tumors and could potentially skew experimental results. And there is some evidence that iPS cells aren't exactly like embryonic stem cells in their gene expression, retaining a subtle cellular memory of the tissue they came from. The method is also relatively inefficient, reprogramming only about one out of 1000 cells exposed to the treatment, and it takes more than a month for iPS cells to appear.

The new technique goes a long way toward fixing those problems. Stem cell researcher Derrick Rossi of Harvard Medical School in Boston and his colleagues used synthetic RNA molecules that correspond to the genes inserted in classic reprogramming techniques. The technique makes iPS cells in about half the time, they reported online last week in Cell Stem Cell. And because the RNA quickly breaks down, the reprogrammed cells are genetically identical to the source cells.

Rossi says his first attempts to use RNA to induce protein production were stymied by cells' innate antiviral defenses, which attack foreign RNA and can trigger programmed cell death. But he and his colleagues discovered that by substituting slightly modified versions for two of RNA's usual bases, they could make synthetic RNAs that the cell accepted as its own. By inhibiting interferon—a key part of the cells' anti-RNA defense—they got the cells to express even more of the desired proteins. When the researchers applied a daily cocktail of these synthetic RNAs to connective tissue cells called fibroblasts, the cells dedifferentiated into embryoniclike cells. The team calls its cells RiPS cells, for RNA-induced pluripotent stem cells.

To the team's surprise, the process took just over 2 weeks and reprogrammed as many as 4% of the cells in the culture dish. That makes it roughly 100 times more efficient than the gene-transfer technique and twice as fast. Other researchers have been racing to find other methods to reprogram cells, but most of them have proved less efficient than the classic technique.

Further experiments suggest that the RNA approach does a more thorough job of reprogramming the cell than other methods. The genes that RiPS cells express are very similar to those expressed by ES cells—in other words, they seem to be a closer match to ES cells than most iPS cells to date. The method can also prompt cells to become nonembryonic cell types. By inserting synthetic RNA that codes for a key gene in muscle tissue, for example, the researchers could turn both fibroblasts and RiPS cells into muscle cells.

"I'm so impressed ... that we are going to turn over our entire iPS core to this new method to make stem cells from patients with all sorts of diseases," says stem cell researcher Douglas Melton of Harvard's Stem Cell Institute. "It is a major advance."

Rossi says the synthetic RNAs will be easy for other labs to make: "If you have basic molecular biology tools, you can make these RNAs." Still, Ichida says he is not giving up his search for a suite of chemicals that can reprogram cells. For researchers who might want to make thousands of iPS cell lines, he says, RNA reprogramming will still be time-consuming and expensive, and a chemical cocktail could prove even more efficient, he says. Others agree. Although he says the RNA technique is a significant advance, stem cell researcher James Thomson of the University of Wisconsin, Madison, says it is too early to discount other approaches to reprogramming.

The RNA technique could have uses beyond the stem cell field, Rossi and others note. The modified RNA can also prompt cells to make designer proteins, Rossi says. And developmental biologists can use it to better understand the effects of certain genes. "It's the flip side of RNAi," Rossi says, referring to a widely used technique in which scientists use RNA to block the expression of genes in cells. Rossi says he will be exploring how to use the RNA-prompted protein expression to replace proteins in diseased patients. "If we could reprogram somatic human fibroblasts to pluripotency, you can do anything with this technology," he says.

http://www.sciencemag.org/cgi/content/full/330/6001/162
  • 邀请讨论
  • 不知道邀请谁?试试他们

    换一换
2010-10-15 11:38 浏览 : 803 回复 : 5
  • 投票
  • 收藏 2
  • 打赏
  • 引用
  • 分享
    • 微信扫一扫

    • 新浪微博
    • 丁香客
    • 复制网址
  • 举报
    • 广告宣传推广
    • 政治敏感、违法虚假信息
    • 恶意灌水、重复发帖
    • 违规侵权、站友争执
    • 附件异常、链接失效
    • 其他
  • • 【规培笔记128】—工作报告偶遇,颅脑MR,您能看出几处异常?据说工作中很罕见!
楼主 inflyings
inflyings
铁杆站友

  • 11
    积分
  • 4
    得票
  • 144
    丁当
  • 2楼
期待这篇大作的诞生吧
传统的
DNA-based virus transfected into cell--->Cell incorporates DNA into its genome--->
Cell makes RNA from inserted genes--->Cell uses RNA to make protein--->Proteins trigger reprogramming,cell becomes pluripotent,DNA remains altered
改良版
Synthetic RNA transfected into cell--->Cell uses RNA to make protein--->Proteins trigger reprogramming,cell becomes pluripotent,DNA remains unchanged

science report

  • New Technique RiPS Open Stem Cell Field.pdf(1111.05k)
2010-10-15 11:47
  • 投票
  • 收藏
  • 打赏
  • 引用
  • 分享
    • 微信扫一扫

    • 新浪微博
    • 丁香客
    • 复制网址
  • 举报
    • 广告宣传推广
    • 政治敏感、违法虚假信息
    • 恶意灌水、重复发帖
    • 违规侵权、站友争执
    • 附件异常、链接失效
    • 其他
  • • 死亡患者危重讨论怎么写?
楼主 inflyings
inflyings
铁杆站友

  • 11
    积分
  • 4
    得票
  • 144
    丁当
  • 3楼
从DNA到RNA,下次不知道有没有可能直接实现从蛋白质水平上改变细胞性状呢,哈哈哈,可能性不大吧。。。。
2010-10-15 11:49
  • 投票
  • 收藏
  • 打赏
  • 引用
  • 分享
    • 微信扫一扫

    • 新浪微博
    • 丁香客
    • 复制网址
  • 举报
    • 广告宣传推广
    • 政治敏感、违法虚假信息
    • 恶意灌水、重复发帖
    • 违规侵权、站友争执
    • 附件异常、链接失效
    • 其他
  • • 一图解读|血常规化验单
yingtiao
yingtiao

丁香园荣誉版主

  • 314
    积分
  • 164
    得票
  • 70
    丁当
  • 4楼
本人认领该文翻译,24小时之内完成,如未完成,请其他战友自由认领。
2010-10-17 08:28
  • 投票
  • 收藏
  • 打赏
  • 引用
  • 分享
    • 微信扫一扫

    • 新浪微博
    • 丁香客
    • 复制网址
  • 举报
    • 广告宣传推广
    • 政治敏感、违法虚假信息
    • 恶意灌水、重复发帖
    • 违规侵权、站友争执
    • 附件异常、链接失效
    • 其他
  • • 一个读研期间执医四战四败的医学生内心独白

关闭提示

需要2个丁当

丁香园旗下网站

  • 丁香园
  • 用药助手
  • 丁香通
  • 文献求助
  • 丁香人才
  • 丁香医生
  • 丁香导航
  • 丁香会议
  • 手机丁香园
  • 医药数据库

关于丁香园

  • 关于我们
  • 丁香园标志
  • 友情链接
  • 联系我们
  • 加盟丁香园
  • 版权声明
  • 资格证书

官方链接

  • 丁香志
  • 丁香园新浪微博
引用回复